Silencing of AC099850.3 inhibited HCC cell proliferation and migration and led to significant inhibition of PLK1, TTK, CDK1, and BULB1 cell cycle molecules and CD155 and PDL1 immune receptors (23). The gene discussed is PLK1; the disease is hepatocellular carcinoma.